The Efficacy and Sequencing of a Short Course of Androgen Suppression on Freedom From Biochemical Failure When Administered With Radiation Therapy for T2-T3 Prostate Cancer-Reference-Cited by-同舟云学术

The Efficacy and Sequencing of a Short Course of Androgen Suppression on Freedom From Biochemical Failure When Administered With Radiation Therapy for T2-T3 Prostate Cancer

Published:2004-03 Issue:3 Volume:171 Page:1137-1140
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

LAVERDIÈRE JACQUES¹,NABID ABDENOUR¹,DE BEDOYA LUIS DIAZ¹,ÉBACHER ANNIE¹,FORTIN ANDRÉ¹,WANG CHANG SHU¹,HAREL FRANÇOIS¹

Affiliation:

1. From the Departments of Radiation Oncology, Centre Hospitalier Universitaire de Quebec, Hôtel-Dieu de Québec, Laval University (JL, LDDB, AE, AF, CSW, FH) and Sherbrooke University (AN), Quebec, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy;Kupelian;J Clin Oncol,2002

2. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

3. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31;Pilepich;J Clin Oncol,1997

4. Down-staging of early stage prostate cancer: the first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist;Labrie;Urology,1995

5. A phase III trial of androgen suppression before and during radiation therapy (RT) for locally advanced prostatic: preliminary report of RTOG protocol 8610;Pilepich;Proc Am Soc Clin Oncol,1993

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining androgen deprivation and radiation therapy in the treatment of localised prostate cancer: Summary of level 1 evidence and current gaps in knowledge;Clinical and Translational Radiation Oncology;2022-11

2. Clinical Case Debate: Immunotherapy Versus Alternative Therapies in the Neoadjuvant and Adjuvant Setting of Localized, High-Risk Prostate Cancer;Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers;2022

3. Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis;Journal of Clinical Oncology;2021-01-10

4. Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial;European Journal of Cancer;2021-01

5. Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group;Cancer/Radiothérapie;2020-12